Hassan Syed Shah, Tiwari Sandeep, Guimarães Luís Carlos, Jamal Syed Babar, Folador Edson, Sharma Neha Barve, de Castro Soares Siomar, Almeida Síntia, Ali Amjad, Islam Arshad, Póvoa Fabiana Dias, de Abreu Vinicius Augusto Carvalho, Jain Neha, Bhattacharya Antaripa, Juneja Lucky, Miyoshi Anderson, Silva Artur, Barh Debmalya, Turjanski Adrian Gustavo, Azevedo Vasco, Ferreira Rafaela Salgado
BMC Genomics. 2014;15 Suppl 7(Suppl 7):S3. doi: 10.1186/1471-2164-15-S7-S3. Epub 2014 Oct 27.
Corynebacterium pseudotuberculosis (Cp) is a pathogenic bacterium that causes caseous lymphadenitis (CLA), ulcerative lymphangitis, mastitis, and edematous to a broad spectrum of hosts, including ruminants, thereby threatening economic and dairy industries worldwide. Currently there is no effective drug or vaccine available against Cp. To identify new targets, we adopted a novel integrative strategy, which began with the prediction of the modelome (tridimensional protein structures for the proteome of an organism, generated through comparative modeling) for 15 previously sequenced C. pseudotuberculosis strains. This pan-modelomics approach identified a set of 331 conserved proteins having 95-100% intra-species sequence similarity. Next, we combined subtractive proteomics and modelomics to reveal a set of 10 Cp proteins, which may be essential for the bacteria. Of these, 4 proteins (tcsR, mtrA, nrdI, and ispH) were essential and non-host homologs (considering man, horse, cow and sheep as hosts) and satisfied all criteria of being putative targets. Additionally, we subjected these 4 proteins to virtual screening of a drug-like compound library. In all cases, molecules predicted to form favorable interactions and which showed high complementarity to the target were found among the top ranking compounds. The remaining 6 essential proteins (adk, gapA, glyA, fumC, gnd, and aspA) have homologs in the host proteomes. Their active site cavities were compared to the respective cavities in host proteins. We propose that some of these proteins can be selectively targeted using structure-based drug design approaches (SBDD). Our results facilitate the selection of C. pseudotuberculosis putative proteins for developing broad-spectrum novel drugs and vaccines. A few of the targets identified here have been validated in other microorganisms, suggesting that our modelome strategy is effective and can also be applicable to other pathogens.
伪结核棒状杆菌(Cp)是一种致病菌,可导致干酪性淋巴结炎(CLA)、溃疡性淋巴管炎、乳腺炎,并可使包括反刍动物在内的广泛宿主发生水肿,从而对全球经济和乳制品行业构成威胁。目前尚无针对Cp的有效药物或疫苗。为了确定新的靶点,我们采用了一种新颖的综合策略,该策略首先通过比较建模预测了15株先前测序的伪结核棒状杆菌菌株的模型组(通过比较建模生成的生物体蛋白质组的三维蛋白质结构)。这种泛模型组学方法鉴定出一组331种保守蛋白质,它们在种内具有95 - 100%的序列相似性。接下来,我们将消减蛋白质组学和模型组学相结合,揭示了一组10种可能对该细菌至关重要的Cp蛋白。其中,4种蛋白(tcsR、mtrA、nrdI和ispH)是必需的且无宿主同源物(将人、马、牛和羊视为宿主),并满足作为假定靶点的所有标准。此外,我们对这4种蛋白进行了类药物化合物库的虚拟筛选。在所有情况下,在排名靠前的化合物中都发现了预测会形成有利相互作用且与靶点具有高度互补性的分子。其余6种必需蛋白(adk、gapA、glyA、fumC、gnd和aspA)在宿主蛋白质组中有同源物。我们比较了它们的活性位点腔与宿主蛋白质中的相应腔。我们提出,其中一些蛋白可以使用基于结构的药物设计方法(SBDD)进行选择性靶向。我们的结果有助于选择伪结核棒状杆菌的假定蛋白以开发广谱新型药物和疫苗。这里鉴定出的一些靶点已在其他微生物中得到验证,这表明我们的模型组学策略是有效的,并且也可应用于其他病原体。